Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 8.463\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CN1CCN(CC(=O)Nc2nnc(-c3cccs3)s2)CC1
(b) C[C@@]12CCC=C[C@H]1[C@H](c1ccc3ccccc3c1)N(Cc1ccccc1)C2=O
(c) CCC(=O)NCCc1nc2cc(NC(=O)c3ccccc3Cl)ccc2n1C
Answer: c. CCC(=O)NCCc1nc2cc(NC(=O)c3ccccc3Cl)ccc2n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)NCCc1nc2cc(NC(=O)c3ccccc3Cl)ccc2n1C
CCC(=O)NCCc1nc2cc(NC(=O)c3ccccc3Cl)ccc2n1C
2-chloro-N-[1-methyl-2-[2-(propanoylamino)ethyl]benzimidazol-5-yl]benzamide